Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravitreal triamcinolone for the treatment of diabetic macular edema.
Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M. Gómez-Ulla F, et al. Among authors: rothen m. Curr Diabetes Rev. 2006 Feb;2(1):99-112. doi: 10.2174/157339906775473572. Curr Diabetes Rev. 2006. PMID: 18220620 Review.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group. Ip MS, et al. Arch Ophthalmol. 2009 Sep;127(9):1101-14. doi: 10.1001/archophthalmol.2009.234. Arch Ophthalmol. 2009. PMID: 19752419 Free PMC article. Clinical Trial.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M; SCORE Study Research Group. Scott IU, et al. Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233. Arch Ophthalmol. 2009. PMID: 19752420 Free PMC article. Clinical Trial.
Anti-macular degeneration agents.
Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd. Rothen M, et al. Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. doi: 10.1016/j.ohc.2005.07.009. Ophthalmol Clin North Am. 2005. PMID: 16314219 Review.
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.
Jenkins AJ, Rothen M, Klein RL, Moller K, Eldridge L, Zheng D, Durazo-Arvizu R, McGee D, Lackland D, Thorpe SR, Garvey WT, Lyons TJ; DCCT/EDIC Research Group. Jenkins AJ, et al. Among authors: rothen m. J Diabetes Complications. 2008 May-Jun;22(3):153-63. doi: 10.1016/j.jdiacomp.2007.02.003. Epub 2008 Apr 16. J Diabetes Complications. 2008. PMID: 18413218
Using sequential applications of a novel silver diamine fluoride gel and sodium fluoride varnish to arrest severe early childhood caries lesions: A clinical trial with single group assignment.
Padilla Cáceres TC, Cervantes-Alagón S, Castillo JL, Vera Reyes CM, Rothen M, Mancl LA, Milgrom P. Padilla Cáceres TC, et al. Among authors: rothen m. J Am Dent Assoc. 2024 Jun;155(6):526-535. doi: 10.1016/j.adaj.2024.02.013. Epub 2024 Apr 25. J Am Dent Assoc. 2024. PMID: 38678451 Free article. Clinical Trial.
71 results